bankruptcy

Mallinckrodt preps a possible bankruptcy amid a maelstrom of opioid claims — report
Mallinckrodt preps a possible bankruptcy amid a maelstrom of opioid claims — report
Endpoints
Mallinckrodt
opioids
opioid crisis
bankruptcy
Flag link:
Bankrupt uBiome Says Founders May Have Misled Investors
Bankrupt uBiome Says Founders May Have Misled Investors
Xconomy
uBiome
microbiome
bankruptcy
Flag link:
States Pause Lawsuits Against Insys During Bankruptcy Proceedings
States Pause Lawsuits Against Insys During Bankruptcy Proceedings
BioSpace
INSYS Therapeutics
bankruptcy
Flag link:
Insys Therapeutics Files for Bankruptcy Following Legal Trouble
Insys Therapeutics Files for Bankruptcy Following Legal Trouble
BioSpace
INSYS Therapeutics
opioids
Subsys
bankruptcy
Flag link:
Achaogen’s bankruptcy and going-out-of-business sale offer a grim cautionary tale for the future of antibiotic development
Achaogen’s bankruptcy and going-out-of-business sale offer a grim cautionary tale for the future of antibiotic development
Endpoints
Achaogen
bankruptcy
antibiotics
drug development
Flag link:
Achaogen Eyes Sale in Bankruptcy Auction a Year After FDA Approval
Achaogen Eyes Sale in Bankruptcy Auction a Year After FDA Approval
Xconomy
Achaogen
bankruptcy
Chapter 11
Zemdri
Flag link:
If Purdue Pharma declares bankruptcy, what would it mean for lawsuits against the opioid manufacturer?
If Purdue Pharma declares bankruptcy, what would it mean for lawsuits against the opioid manufacturer?
Stat
Purdue Pharma
opioids
opioid crisis
oxycontin
bankruptcy
Flag link:
Throwing in the towel, troubled antibiotic maker Aradigm files for Chapter 11
Throwing in the towel, troubled antibiotic maker Aradigm files for Chapter 11
Endpoints
Aradigm
antibiotics
bankruptcy
Apulmiq
Flag link:
To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health
To Cover Debts, Synergy Inks $200M Bankruptcy Sale to Bausch Health
Xconomy
Synergy Pharmaceuticals
bankruptcy
Bausch Health
M&A
Flag link:
What We Can Learn From Synergy Pharmaceuticals' Disastrous News
What We Can Learn From Synergy Pharmaceuticals' Disastrous News
Motley Fool
Synergy Pharmaceuticals
Trulance
debt
bankruptcy
Flag link:
Orexigen’s Weight-Loss Roller Coaster to End With a Bankruptcy Sale
Orexigen’s Weight-Loss Roller Coaster to End With a Bankruptcy Sale
Xconomy
Orexigen
bankruptcy
Contrave
Flag link:
Who made lots of money from this biotech bankruptcy? Hint: It wasn't Martin Shkreli
Who made lots of money from this biotech bankruptcy? Hint: It wasn't Martin Shkreli
Bizjournals.com
KaloBios
bankruptcy
Martin Shkreli
Flag link:
KaloBios beats bankruptcy, bets future on Chagas treatment
KaloBios beats bankruptcy, bets future on Chagas treatment
BioPharma Dive
KaloBios
bankruptcy
Chagas disease
benznidazole
Martin Shkreli
Flag link:
MannKind: It's Not Bankruptcy, But...
MannKind: It's Not Bankruptcy, But...
Seeking Alpha
MannKind
bankruptcy
Flag link:
MannKind Is On Its Way To Bankruptcy - Are Executives Jumping This Sinking Ship?
MannKind Is On Its Way To Bankruptcy - Are Executives Jumping This Sinking Ship?
Seeking Alpha
MannKind
Sanofi
Afrezza
bankruptcy
Flag link:
Why MannKind Is Heading Towards Bankruptcy
Why MannKind Is Heading Towards Bankruptcy
Seeking Alpha
MannKind
Sanofi
Pfizer
bankruptcy
Afrezza
Flag link:
MannKind Corp. Sinks Again On Bankruptcy Concerns
MannKind Corp. Sinks Again On Bankruptcy Concerns
Motley Fool
MannKind
bankruptcy
Afrezza
Sanofi
inhaled insulin
diabetes
Flag link:
KaloBios Pharmaceuticals Inc Bankrupcy Filing May Offer One Last Breather
KaloBios Pharmaceuticals Inc Bankrupcy Filing May Offer One Last Breather
Bidness, ETC
KaloBios
bankruptcy
NASDAQ
Martin Shkreli
Flag link:
Shkreli's Former Company KaloBios Files for Bankruptcy
Shkreli's Former Company KaloBios Files for Bankruptcy
Bloomberg
KaloBios
bankruptcy
Martin Shkreli
Flag link:
MannKind Migrates to Israel to Stave Off Bankruptcy
MannKind Migrates to Israel to Stave Off Bankruptcy
TheStreet.com
MannKind
bankruptcy
Israel
Afrezza
Flag link:

Pages